Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|July 21, 1998
beta-Lactam derivatives as inhibitors of human cytomegalovirus proteaseC Yoakim, W W Ogilvie, D R Cameron, et al.Bioorganic & Medicinal Chemistry Letters|October 31, 2000
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domainS R LaPlante, N Aubry, P R Bonneau, et al.Antiviral Chemistry & Chemotherapy|January 6, 1999
Potent beta-lactam inhibitors of human cytomegalovirus proteaseC Yoakim, W W Ogilvie, D R Cameron, et al.Biochemistry|July 10, 1998
Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformationS R LaPlante, N Aubry, P R Bonneau, et al.The Journal of Antimicrobial Chemotherapy|June 9, 2023
Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicinJ Nowakowska, D R Cameron, A De Martino, et al.Journal of Medicinal Chemistry|March 29, 2000
2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitorsP L Beaulieu, P C Anderson, D R Cameron, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 12, 2017
Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitorsD R Cameron, Y-H Lin, S Trouillet-Assant, et al.Journal of Medicinal Chemistry|March 3, 1999
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domainM Llinaś-Brunet, P L Beaulieu, D R Cameron, et al.Journal of Medicinal Chemistry|May 29, 1999
Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacementsP L Beaulieu, D R Cameron, J M Ferland, et al.Journal of Medicinal Chemistry|July 13, 2001
Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domainJ R Proudfoot, R Betageri, M Cardozo, et al.Pageof 2